ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla
Ann Surg Oncol
.
2022 Aug;29(8):4725-4726.
doi: 10.1245/s10434-022-11767-y.
Epub 2022 Apr 12.
Authors
Maggie L DiNome
1
,
Diego M Marzese
2
Affiliations
1
Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.dinome@duke.edu.
2
Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain.
PMID:
35415817
DOI:
10.1245/s10434-022-11767-y
No abstract available
MeSH terms
Axilla
Biomarkers
Breast Neoplasms* / surgery
Female
Humans
Neoadjuvant Therapy*
Substances
Biomarkers